These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 17201722

  • 21. Determinants of success in the use of oral levetiracetam in status epilepticus.
    Rossetti AO, Bromfield EB.
    Epilepsy Behav; 2006 May; 8(3):651-4. PubMed ID: 16495155
    [Abstract] [Full Text] [Related]

  • 22. Levetiracetam: a new therapeutic option for refractory epilepsy.
    Pinto A, Sander JW.
    Int J Clin Pract; 2003 Sep; 57(7):616-21. PubMed ID: 14529064
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study.
    López-Góngora M, Martínez-Domeño A, García C, Escartín A.
    Epileptic Disord; 2008 Dec; 10(4):297-305. PubMed ID: 19017572
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
    Delanty N, Jones J, Tonner F.
    Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
    [Abstract] [Full Text] [Related]

  • 31. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
    Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Orman CB, Gauer LJ, Lu Z, N159 Study Group.
    Neurology; 2006 Jun 13; 66(11):1654-60. PubMed ID: 16641323
    [Abstract] [Full Text] [Related]

  • 32. Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats.
    Brandt C, Glien M, Gastens AM, Fedrowitz M, Bethmann K, Volk HA, Potschka H, Löscher W.
    Neuropharmacology; 2007 Aug 13; 53(2):207-21. PubMed ID: 17585956
    [Abstract] [Full Text] [Related]

  • 33. Levetiracetam add-on therapy in Japanese patients with refractory partial epilepsy.
    Tanaka S, Tanaka T.
    Epileptic Disord; 2013 Jun 13; 15(2):132-41. PubMed ID: 23774199
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Measurement of seizure freedom in adjunctive therapy studies in refractory partial epilepsy: the levetiracetam experience.
    Leppik I, De Rue K, Edrich P, Perucca E.
    Epileptic Disord; 2006 Jun 13; 8(2):118-30. PubMed ID: 16793573
    [Abstract] [Full Text] [Related]

  • 38. Levetiracetam in children with refractory status epilepticus.
    Gallentine WB, Hunnicutt AS, Husain AM.
    Epilepsy Behav; 2009 Jan 13; 14(1):215-8. PubMed ID: 18926926
    [Abstract] [Full Text] [Related]

  • 39. Role of intravenous levetiracetam in acute seizure management of children.
    Kirmani BF, Crisp ED, Kayani S, Rajab H.
    Pediatr Neurol; 2009 Jul 13; 41(1):37-9. PubMed ID: 19520272
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.